Viral Genetic Diversity and Its Potential Contributions to the Development and Progression of Neonatal Herpes Simplex Virus (HSV) Disease

Keyphrases

• Potential Contribution 100%
• Clinical Outcomes 100%
• Herpes Simplex Virus 100%
• Neonatal Infection 100%
• Virus Diseases 100%
• Viral Genetic Diversity 100%
• Neonatal Herpes 100%
• Herpes Simplex Virus Type 1 (HSV-1) 50%
• Herpes Simplex Virus 2 (HSV-2) 50%
• Skin Lesions 50%
• Antiretroviral Therapy 50%
• Diagnostic Ratios 50%
• Clinical Course 50%
• Herpes Simplex Virus Infection 50%
• Clinical Diagnostics 50%
• Statistical Power 50%
• Human Host 50%
• Disseminated Infection 50%
• Central Nervous System Infections 50%
• Neonatal Outcome 50%
• New Parents 50%
• Clinical Impact 50%
• Viral Spread 50%
• Neonatal HSV Infection 50%

Medicine and Dentistry

• Virus Infection 100%
• Genetic Variability 100%
• Herpes Simplex Virus 100%
• Infection 66%
• Newborn Infection 66%
• Diagnosis 33%
• Herpes Simplex Virus 2 33%
• Human Alphaherpesvirus 1 33%
• Disease Course 33%
• Skin Defect 33%
• Central Nervous System Infection 33%
• Antiviral Therapy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Virus Infection 100%
• Herpes Simplex Virus 100%
• Infection 66%
• Herpes Simplex Virus 2 33%
• Human Alphaherpesvirus 1 33%
• Disease Course 33%
• Skin Defect 33%
• Antiviral Therapy 33%
• Central Nervous System Infection 33%